Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.

MLA

Jagadeeswaran, Ramasamy, et al. “Pharmacological Inhibition of LSD1 and MTOR Reduces Mitochondrial Retention and Associated ROS Levels in the Red Blood Cells of Sickle Cell Disease.” Experimental Hematology, vol. 50, June 2017, pp. 46–52. EBSCOhost, https://doi.org/10.1016/j.exphem.2017.02.003.

APA

Jagadeeswaran, R., Vazquez, B. A., Thiruppathi, M., Ganesh, B. B., Ibanez, V., Cui, S., Engel, J. D., Diamond, A. M., Molokie, R. E., DeSimone, J., Lavelle, D., & Rivers, A. (2017). Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Experimental Hematology, 50, 46–52. https://doi.org/10.1016/j.exphem.2017.02.003

Chicago

Jagadeeswaran, Ramasamy, Benjamin A Vazquez, Muthusamy Thiruppathi, Balaji B Ganesh, Vinzon Ibanez, Shuaiying Cui, James D Engel, et al. 2017. “Pharmacological Inhibition of LSD1 and MTOR Reduces Mitochondrial Retention and Associated ROS Levels in the Red Blood Cells of Sickle Cell Disease.” Experimental Hematology 50 (June): 46–52. doi:10.1016/j.exphem.2017.02.003.